Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Motor Fluctuations”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00357994
What this trial is testing

Study of Efficacy, Safety and Tolerability of Levodopa-Carbidopa Intestinal Gel in Levodopa-Responsive Parkinson's Subjects

Who this might be right for
Advanced Parkinson's Disease
AbbVie (prior sponsor, Abbott) 36
Large-scale testing (Phase 3)Study completedNCT01187966
What this trial is testing

Efficacy and Safety of Safinamide (50 and 100mg/Day) Versus Placebo, in Patients With Mid-late Stage Parkinson's Disease

Who this might be right for
Parkinson's Disease
Newron Pharmaceuticals SPA 669
Testing effectiveness (Phase 2)Study completedNCT01229332
What this trial is testing

A Safety, Tolerability and Pharmacokinetic Study of ND0611 on the Top of Different Oral Dosage Forms of Levodopa/Carbidopa in Parkinson's Disease Patients

Who this might be right for
Parkinson's Disease
NeuroDerm Ltd. 24
Large-scale testing (Phase 3)Study completedNCT00203034
What this trial is testing

Multicenter Study of Rasagiline in Parkinson's Disease Patients Using Levodopa and Experiencing Motor Fluctuations

Who this might be right for
Parkinson's Disease
Teva Branded Pharmaceutical Products R&D, Inc. 472
Large-scale testing (Phase 3)Study completedNCT02242487
What this trial is testing

Twelve Month Safety and Efficacy Study of CVT-301 In Parkinson's Disease Patients With OFF Episodes

Who this might be right for
Idiopathic Parkinson's Disease
Acorda Therapeutics 325
Large-scale testing (Phase 3)Ended earlyNCT00360412
What this trial is testing

E2007 as an Adjunctive Therapy in Levodopa Treated Parkinson's Disease Patients With Motor Fluctuations

Who this might be right for
Parkinson's Disease
Eisai Inc. 997
Testing effectiveness (Phase 2)Study completedNCT00406029
What this trial is testing

Dyskinesia in Parkinson's Disease (Study P04501)

Who this might be right for
Parkinson DiseaseMovement DisordersCentral Nervous System Diseases+2 more
Merck Sharp & Dohme LLC 253
Not applicableStudy completedNCT05247294
What this trial is testing

Assessment of Fluctuating Parkinson's Disease With Sensor-based Home Monitoring

Who this might be right for
Parkinson Disease
Sheba Medical Center 24
Not applicableLooking for participantsNCT07798271
What this trial is testing

Optimizing Adaptive DBS for Parkinson's Disease

Who this might be right for
PARKINSON DISEASE (Disorder)
University of California, Davis 35
Testing effectiveness (Phase 2)Study completedNCT03608371
What this trial is testing

BTRX-246040 Study in Participants With Parkinson's Disease With Motor Fluctuations

Who this might be right for
Parkinson DiseaseMotor Disorder
BlackThorn Therapeutics, Inc. 24
Large-scale testing (Phase 3)Study completedNCT00660387
What this trial is testing

Study of Efficacy, Safety and Tolerability of Levodopa-Carbidopa Intestinal Gel in Levodopa-Responsive Parkinson's Subjects

Who this might be right for
Advanced Parkinson's Disease
AbbVie (prior sponsor, Abbott) 35
Not applicableStudy completedNCT02815800
What this trial is testing

Efficacy of Ethnodyne Visio in Parkinson's Disease

Who this might be right for
Parkinson's Disease
University Hospital, Strasbourg, France 24
Not applicableStudy completedNCT02859805
What this trial is testing

Validation of a Diagnostic Self-assessment Scale Non-motor Fluctuations at the Parkinson's Patient

Who this might be right for
Parkinson Disease
Assistance Publique Hopitaux De Marseille 255
Large-scale testing (Phase 3)Ended earlyNCT01536015
What this trial is testing

Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease (PD) With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction

Who this might be right for
Advanced Parkinson's Disease
UCB Pharma 25
Testing effectiveness (Phase 2)Study completedNCT01683292
What this trial is testing

Single-Centre Study of VR040(Inhaled Apomorphine) in Idiopathic Parkinson's Disease

Who this might be right for
Parkinson's Disease
South Glasgow University Hospitals NHS Trust 29
Large-scale testing (Phase 3)Study completedNCT04380142
What this trial is testing

Study Comparing Continuous Subcutaneous Infusion Of ABBV-951 With Oral Carbidopa/Levodopa Tablets For Treatment Of Motor Fluctuations In Adult Participants With Advanced Parkinson's Disease

Who this might be right for
Parkinson's Disease (PD)
AbbVie 174
Large-scale testing (Phase 3)Study completedNCT00286897
What this trial is testing

The Efficacy, Safety and Tolerability of E2007 in Levodopa Treated Parkinson's Disease Patients With Motor Fluctuations

Who this might be right for
Parkinson's Disease
Eisai Limited 702
Early research (Phase 1)Study completedNCT03562494
What this trial is testing

VY-AADC02 for Parkinson's Disease With Motor Fluctuations (RESTORE-1)

Who this might be right for
Parkinson's Disease
Neurocrine Biosciences 14
Large-scale testing (Phase 3)Study completedNCT03670953
What this trial is testing

Evaluate the Safety and Efficacy of IPX203 in Parkinson's Disease Participants With Motor Fluctuations

Who this might be right for
Parkinson's Disease (Disorder)
Impax Laboratories, LLC 630
Post-approval studies (Phase 4)Study completedNCT00143026
What this trial is testing

Study to Compare the Effect of Treatment With Carbidopa/Levodopa/Entacapone on the Quality of Life of Patients With Parkinson's Disease. This Study is Not Recruiting in the United States

Who this might be right for
Parkinson's Disease
Novartis 184
Next Page